This case highlights the potential for primary nodal-EBV-TNKL to develop presumably in the presence of immune dysfunction related to TFH proliferation/lymphoma and possibly aggravated by EBV reactivation, even in the absence of treatment [50]. Here, TNKS2 is linked to lymphoma.